514
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Effect of nintedanib on airway inflammation and remodeling in a murine chronic asthma model

, , , , , , , & ORCID Icon show all
Pages 187-196 | Received 19 Nov 2016, Accepted 02 Jun 2017, Published online: 11 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Lina Wei, Xulei Gou, Baoning Su, Haiqiong Han, Tingting Guo, Liang Liu, Lei Wang, Lina Zhang & Weibin Chen. (2022) Mahuang Decoction Attenuates Airway Inflammation and Remodeling in Asthma via Suppression of the SP1/FGFR3/PI3K/AKT Axis. Drug Design, Development and Therapy 16, pages 2833-2850.
Read now
Kenia Ubieta, Matthew James Thomas & Lutz Wollin. (2021) The Effect of Nintedanib on T-Cell Activation, Subsets and Functions. Drug Design, Development and Therapy 15, pages 997-1011.
Read now
Kyung Hoon Kim, Jung Hur, Hwa Young Lee, Eung Gu Lee & Sook Young Lee. (2021) Cyclo-VEGI inhibits bronchial artery remodeling in a murine model of chronic asthma. Experimental Lung Research 47:10, pages 494-506.
Read now
Ning He, Liping Liu, Juan Ding, Yuemei Sun, Haiyan Xing & Shuyun Wang. (2020) MiR-222-3p ameliorates glucocorticoid-induced inhibition of airway epithelial cell repair through down-regulating GILZ expression. Journal of Receptors and Signal Transduction 40:4, pages 301-312.
Read now
Jongmin Lee, Chin Kook Rhee, Jong Hyuk Lee, Hyon Jee Yoon, In Kyoung Kim, Jung Hur, Ji Young Kang, Hyoung Kyu Yoon, Sook Young Lee & Young Kyoon Kim. (2020) Effect of nintedanib on airway inflammation in a mouse model of acute asthma. Journal of Asthma 57:1, pages 11-20.
Read now

Articles from other publishers (23)

Zeev Elkoshi. (2024) TGF-β, IL-1β, IL-6 levels and TGF-β/Smad pathway reactivity regulate the link between allergic diseases, cancer risk, and metabolic dysregulations. Frontiers in Immunology 15.
Crossref
Malarvizhi Gurusamy, Saeed Nasseri, Dileep Reddy Rampa, Huiying Feng, Dongwon Lee, Anton Pekcec, Henri Doods & Dongmei Wu. (2023) Triple-tyrosine kinase inhibition by BIBF1000 attenuates airway and pulmonary arterial remodeling following chronic allergen challenges in mice. European Journal of Medical Research 28:1.
Crossref
Avanka Gunatilaka, Stephanie Zhang, Wan Shun Daniel Tan & Alastair G. Stewart. 2023. Pulmonary Pharmacology. Pulmonary Pharmacology 179 224 .
Annette D. Rieg, Said Suleiman, Carolin Anker, Nina A. Bünting, Eva Verjans, Jan Spillner, Sebastian Kalverkamp, Saskia von Stillfried, Till Braunschweig, Stefan Uhlig & Christian Martin. (2022) Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca2+-sensitisation. Respiratory Research 23:1.
Crossref
Joon Young Choi, Jung Hur, Sora Jeon, Chan Kwon Jung & Chin Kook Rhee. (2022) Effects of human adipose tissue- and bone marrow-derived mesenchymal stem cells on airway inflammation and remodeling in a murine model of chronic asthma. Scientific Reports 12:1.
Crossref
Vladimir V. Chrishtop, Artur Y. Prilepskii, Varvara G. Nikonorova & Vladimir A. Mironov. (2021) Nanosafety vs. nanotoxicology: adequate animal models for testing in vivo toxicity of nanoparticles. Toxicology 462, pages 152952.
Crossref
Ke-Jia Cheng, Min-Li Zhou, Yong-Cai Liu, Chen Wang & Ying-Ying Xu. (2021) The Role of CD40 in Allergic Rhinitis and Airway Remodelling. Mediators of Inflammation 2021, pages 1-9.
Crossref
Robin Deterding, Matthias Griese, Gail Deutsch, David Warburton, Emily M. DeBoer, Steven Cunningham, Annick Clement, Nicolaus Schwerk, Kevin R. Flaherty, Kevin K. Brown, Florian Voss, Ulrike Schmid, Rozsa Schlenker-Herceg, Daniela Verri, Mihaela Dumistracel, Marilisa Schiwek, Susanne Stowasser, Kay Tetzlaff, Emmanuelle Clerisme-Beaty & Lisa R. Young. (2021) Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease. ERJ Open Research 7:2, pages 00805-2020.
Crossref
Renata Virgínia Cavalcanti Santos, Eudes Gustavo Constantino Cunha, Gabriela Souto Vieira de Mello, José Ângelo Rizzo, Jamerson Ferreira de Oliveira, Maria do Carmo Alves de Lima, Ivan da Rocha Pitta, Maira Galdino da Rocha Pitta & Moacyr Jesus Barreto de Melo Rêgo. (2021) New Oxazolidines Inhibit the Secretion of IFN-γ and IL-17 by PBMCS from Moderate to Severe Asthmatic Patients. Medicinal Chemistry 17:3, pages 289-297.
Crossref
YONGLI ZHANG, YIZHAN CAO, BO ZHU, YANNI JIANG & PENGCHONG LIANG. (2021) LncRNA NKILA suppresses airway hyper reactivity via interfering the facilitation of MUC5AC and MUC5B mediated by GALNT2. BIOCELL 45:1, pages 41-48.
Crossref
Wangao Zhang, Pengju Chen, Huimin Zong, Yikun Ding & Ruhu Yan. (2020) MiR-143-3p targets ATG2B to inhibit autophagy and promote endothelial progenitor cells tube formation in deep vein thrombosis. Tissue and Cell 67, pages 101453.
Crossref
Yang Zhao, Sumei Liu, Xiangsheng Li, Zhenzhen Xu, Lifang Hao, Zhe Cui, Kewei Bi, Yanfen Zhang & Zhongcheng Liu. (2020) Cross-talk of Signaling Pathways in the Pathogenesis of Allergic Asthma and Cataract. Protein & Peptide Letters 27:9, pages 810-822.
Crossref
Asoka BannoAravind T. ReddySowmya P. LakshmiRaju C. Reddy. (2020) Bidirectional interaction of airway epithelial remodeling and inflammation in asthma. Clinical Science 134:9, pages 1063-1079.
Crossref
Emilia Bigaeva, Elisabeth G. D. Stribos, Henricus A. M. Mutsaers, Bram Piersma, Anna M. Leliveld, Igle J. de Jong, Ruud A. Bank, Marc A. Seelen, Harry van Goor, Lutz Wollin, Peter Olinga & Miriam Boersema. (2020) Inhibition of tyrosine kinase receptor signaling attenuates fibrogenesis in an ex vivo model of human renal fibrosis. American Journal of Physiology-Renal Physiology 318:1, pages F117-F134.
Crossref
Nicholas G. Jendzjowsky & Margaret M. Kelly. (2019) The Role of Airway Myofibroblasts in Asthma. Chest 156:6, pages 1254-1267.
Crossref
Aryeh Fischer & Jörg Distler. (2019) Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases. Clinical Rheumatology 38:10, pages 2673-2681.
Crossref
Lutz Wollin, Jörg H.W. Distler, Elizabeth F. Redente, David W.H. Riches, Susanne Stowasser, Rozsa Schlenker-Herceg, Toby M. Maher & Martin Kolb. (2019) Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases. European Respiratory Journal 54:3, pages 1900161.
Crossref
Toby M. Maher & Wim Wuyts. (2019) Management of Fibrosing Interstitial Lung Diseases. Advances in Therapy 36:7, pages 1518-1531.
Crossref
Vincent Cottin, Lutz Wollin, Aryeh Fischer, Manuel Quaresma, Susanne Stowasser & Sergio Harari. (2019) Fibrosing interstitial lung diseases: knowns and unknowns. European Respiratory Review 28:151, pages 180100.
Crossref
Na-Rae Shin, Hyung-Jun Kwon, Je-Won Ko, Joong-Sun Kim, In-Chul Lee, Jong-Choon Kim, Sung-Hwan Kim & In-Sik Shin. (2019) S-Allyl cysteine reduces eosinophilic airway inflammation and mucus overproduction on ovalbumin-induced allergic asthma model. International Immunopharmacology 68, pages 124-130.
Crossref
P. Heukels, C.C. Moor, J.H. von der Thüsen, M.S. Wijsenbeek & M. Kool. (2019) Inflammation and immunity in IPF pathogenesis and treatment. Respiratory Medicine 147, pages 79-91.
Crossref
Y. Choi, D.‐H. Lee, H. K. T. Trinh, G.‐Y. Ban, H.‐K. Park, Y. S. Shin, S.‐H. Kim & H.‐S. Park. (2018) Surfactant protein D alleviates eosinophil‐mediated airway inflammation and remodeling in patients with aspirin‐exacerbated respiratory disease. Allergy 74:1, pages 78-88.
Crossref
Ajay P. Nayak, Deepak A. Deshpande & Raymond B. Penn. (2018) New targets for resolution of airway remodeling in obstructive lung diseases. F1000Research 7, pages 680.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.